Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORMAT TECHNOLOGIES, INC. Director's Dealing 2025

Sep 30, 2025

6968_dirs_2025-09-30_c5da5c9f-faf1-49f0-9784-5c52269abd0e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORMAT TECHNOLOGIES, INC. (ORA)
CIK: 0001296445
Period of Report: 2025-09-29

Reporting Person: Woelfel Jessica (GC, CCO, and CS)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-09-29 Common Stock M 6401 $78.53 Acquired 11635 Direct
2025-09-29 Common Stock D 5291 $95 Disposed 6344 Direct
2025-09-29 Common Stock M 10000 $69.14 Acquired 15234 Direct
2025-09-29 Common Stock D 7300 $94.64 Disposed 7934 Direct
2025-09-29 Common Stock S 5611 $94.80 Disposed 3433 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-09-29 Stock Appreciation Rights (SARs) $78.53 M 6401 Disposed 2027-03-31 Common Stock (6401) Direct
2025-09-29 Stock Appreciation Rights (SARs) $69.14 M 10000 Disposed 2026-06-15 Common Stock (10000) Direct

Footnotes

F1: Represents the exercise of Stock Appreciation Rights ("SARs") expiring on March 31, 2027, for which the reporting person exercised all 6,401 shares.

F2: This represents the difference between the number of SARs exercised (6,401) and the number of shares issued as a result of the exercise (1,110) The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($95.00) and the exercise price ($78.53).

F3: Represents the exercise of SARs expiring on June 15, 2026, for which the reporting person exercised all 10,000 shares.

F4: This represents the difference between the number of SARs exercised (10,000) and the number of shares issued as a result of the exercise (2,700). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($94.64) and the exercise price ($69.14).

F5: Represents shares of common stock sold in the open market on September 29, 2025 pursuant to a 10b5-1 Plan adopted by the reporting person on 06/30/2025.

F6: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.36 to $95.00, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range specified herein.